The Dow Jones Industrial Average fell 382.15 points, or 0.86%, to 43,910.98, the S&P 500 lost 17.36 points, or 0.29%, to ...
Dynavax Technologies Corporation's flagship product, Heplisav-B, continues to increase market share consistently in a growing ...
The study was based on outcomes seen among essential workers with COVID-19 infection from June 2021 to September 2022.
A total of 438 confirmed and probable cases of meningococcal disease were reported in 2023, the most US cases reported since ...
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
BofA lowered the firm’s price target on Novavax (NVAX) to $12 from $14 and keeps a Neutral rating on the shares. The company announced ...
TD Cowen lowered the firm’s price target on Novavax (NVAX) to $9 from $14 and keeps a Hold rating on the shares. The firm said the FDA lifted its clinical hold on its COVID/flu combo and standalone ...